Despite Justin Bieber’s recent plea for Prince William to pop Propecia, the perilous hair-loss drug is losing market share at a double-digit pace while gaining furious customers at a triple-digit clip.
According to Merck’s quarterly report (SEC Form 10-Q) for the period ended June 30, 2012, Propecia sales totaled $100 million, compared to $112 million for the same period in 2011. That makes for a decline of about 10.5 percent.
Meanwhile, the number of plaintiffs who have filed lawsuits against the pharmaceutical giant, alleging “that they have experienced persistent sexual side effects following cessation of treatment with Propecia and/or Proscar [the same drug, finasteride, in a higher dose, to treat enlarged prostate]” has risen significantly.
